Next Article in Journal
Influence of Manure Application on the Soil Bacterial Microbiome in Integrated Crop-Livestock Farms in Maryland
Previous Article in Journal
Oral Bacterial Microbiota in Digestive Cancer Patients: A Systematic Review
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Comprehensive Contact Tracing, Testing and Sequencing Show Limited Transmission of SARS-CoV-2 between Children in Schools in Norway, August 2020 to May 2021

by
Brita Askeland Winje
1,2,*,
Trine Skogset Ofitserova
1,
Ola Brønstad Brynildsrud
3,
Margrethe Greve-Isdahl
1,
Karoline Bragstad
4,
Rikard Rykkvin
4,
Olav Hungnes
4,
Hilde Marie Lund
5,
Karin Nygård
5,
Hinta Meijerink
1 and
Lin Thorstensen Brandal
5,6
1
Department of Infection Control and Vaccine, Norwegian Institute of Public Health, 0213 Oslo, Norway
2
Faculty of Health Sciences, Oslo Metropolitan University, 0167 Oslo, Norway
3
Department of Method Development and Analytics, Norwegian Institute of Public Health, 0213 Oslo, Norway
4
Department of Virology, Norwegian Institute of Public Health, 0213 Oslo, Norway
5
Department of Infection Control and Preparedness, Norwegian Institute of Public Health, 0213 Oslo, Norway
6
European Program for Public Health Microbiology Training (EUPHEM), European Centre for Disease Prevention and Control, (ECDC), 169 73 Solna, Sweden
*
Author to whom correspondence should be addressed.
Microorganisms 2021, 9(12), 2587; https://doi.org/10.3390/microorganisms9122587
Submission received: 18 November 2021 / Revised: 3 December 2021 / Accepted: 12 December 2021 / Published: 14 December 2021
(This article belongs to the Section Public Health Microbiology)

Abstract

:
The role of children in the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in schools has been a topic of controversy. In this study among school contacts of SARS-CoV-2 positive children in 43 contact-investigations, we investigated SARS-CoV-2 transmission in Norway, August 2020–May 2021. All participants were tested twice within seven to ten days, using SARS-CoV-2 PCR on home-sampled saliva. Positive samples were whole genome sequenced. Among the 559 child contacts, eight tested positive (1.4%, 95% CI 0.62–2.80), with no significant difference between primary (1.0%, 95% CI 0.27–2.53) and secondary schools (2.6%, 95% CI 0.70–6.39), p = 0.229, nor by viral strain, non-Alpha (1.4%, 95% CI 0.50–2.94) and Alpha variant (B.1.1.7) (1.7%, 95% CI 0.21–5.99), p = 0.665. One adult contact (1/100) tested positive. In 34 index cases, we detected 13 different SARS-CoV-2 Pango lineage variants, with B.1.1.7 being most frequent. In the eight contact-investigations with SARS-CoV-2 positive contacts, four had the same sequence identity as the index, one had no relation, and three were inconclusive. With mitigation measures in place, the spread of SARS-CoV-2 from children in schools is limited. By excluding contact-investigations with adult cases known at the time of enrolment, our data provide a valid estimate on the role of children in the transmission of SARS-CoV-2 in schools.

1. Introduction

Many countries adopted school closures and strict infection prevention and control measures (IPC) to limit the spread of SARS-CoV-2, based on the assumption that transmission among children may augment the spread of the virus in the wider community. The high societal costs related to these interventions have invited questions as to whether they are justified, given that children are mostly mildly affected by the virus and mortality rates are very low [1,2].
Children of all ages are susceptible to and may transmit SARS-CoV-2 [3,4], although younger children seem to transmit SARS-CoV-2 less frequently than older children in school settings [3,5]. At the outset of this study, little was known about the role of children in SARS-CoV-2 transmission in schools, specifically the role of asymptomatic infections [6]. Since then, several contact-investigation studies have been published, including a subset of the data included in this report [7], showing limited transmission in schools when appropriate mitigation measures are in place [5]. Yet, the role of children in school transmission is still not completely understood. Asymptomatic and mild symptoms in children may have led to low case-ascertainment of infections in children, specifically early in the pandemic [8]. In addition, the interplay between the school and community incidence challenges the interpretation of data [5], and super-spreading events have also been reported [9].
In Norway, children’s daycare and schools were closed on 13 March 2020, and reopened under strict IPC measures from 20 April 2020. A traffic light model was developed to guide school administrators on IPC strategies [10]. This three-tiered system, with non-pharmaceutical measures, depends on local incidence and infection pressure. The guidelines advised the establishment of cohorts consisting of small permanent groups of children and staff with limited interaction between cohorts, alongside timely testing and isolation of symptomatic cases, and tracing and quarantine of their contacts. Until January 2021, the recommended quarantine period was ten days since the day of last contact, thereafter seven days provided a negative test. The red level indicated smaller cohorts and more restrictive measures [10].
While high vaccination coverage in adults will limit transmission and disease burden, vaccines for younger children are not yet approved. Understanding children’s role in transmission is therefore still important for future mitigation strategies. Feasibility and high sensitivity and specificity of saliva for detection of SARS-CoV-2 by PCR makes this an attractive means for testing of children [11]. To improve knowledge on child-to-child and child-to-adult SARS-CoV-2 transmission in school-settings, we used home-sampled saliva to investigate how many contacts were infected with SARS-CoV-2 after contact with a child with a confirmed SARS-CoV-2 infection at school and whether there was a difference in transmission by age and viral variants.

2. Materials and Methods

Between August 2020 and the end of May 2021, we prospectively followed school contacts of 43 children with laboratory-confirmed SARS-CoV-2 (index cases) who had physically been attending school within 48 h prior to symptom onset or the sampling date for asymptomatic cases. The study included primary (1–7th grade) and secondary (8–10th grade) schools in Oslo and Viken counties. We obtained two self-collected saliva samples from all contacts, at least four days apart, within the seven- to ten-day-long mandatory quarantine period. We excluded contact investigations around child cases in schools with known SARS-CoV-2 infected adults at the time of enrolment. The study was conducted in parallel to measures taken by the local health services.
Local health authorities identified school contacts as per national guidelines. We used the schools’ digital platform to send study invitations to the same school contacts and the index, with one same-day reminder. The school administrations were not involved in any other study procedures. Contacts outside of school were not included. Consent was obtained from all participants aged 16 years or above, or from both parents for participants aged <16 years. In case of sole parental responsibility, a single consent was sufficient.

2.1. Definitions

The index was the child first identified with confirmed SARS-CoV-2 leading to the contact-investigation. A primary case was a contact of the index, who tested positive for SARS-CoV-2 in the first saliva sample. A secondary case was a contact who tested positive for SARS-CoV-2 in the second saliva sample, following a first negative test. A SARS-CoV-2 infected contact was a contact who tested positive in either of the two tests, thus including both the primary and secondary cases. We divided the study-period into before and after the more transmissible Alpha variant (B.1.1.7) was established in the study area (pre-Alpha; August 2020 to February 2021, Alpha; March 2021 to May 2021) [12].

2.2. Demographic and Exposure Data

Participants filled a baseline questionnaire including demographic, exposure and clinical information and a form for daily reporting on the presence or absence of symptoms. Non-cases also filled a questionnaire on recent exposure at the study end (available at https://www.fhi.no/en/studies/corona-child-study/, accessed on 1 December 2021).

2.3. Laboratory Data

At enrolment, all participants were provided with equipment and offered face-to-face and printed instruction on how to home-sample saliva for RdRp gene PCR [13]. Participants were asked to collect 1 mL saliva (not sputum) in the morning, before eating, drinking, or brushing teeth [14]; the first sample was to be collected on the morning after enrolment and the second sample on the morning after the last day of quarantine. Participants added viral transport media to the saliva to preserve the virus during transportation. A study-coordinator was available on site and offered residential delivery and pick-up services to ensure timely transportation for laboratory procedures at the National Reference laboratory of influenza and coronaviruses at the Norwegian Institute of Public Health (NIPH). All saliva samples were tested for the presence of SARS-CoV-2 by rRT-PCR at the Norwegian Institute of Public Health (NIPH). RNA was extracted from samples (200 µL) using MagNaPure 96 DNA and Viral NA Small Volume kits (No. 6543588001, Roche, Basel, Switzerland), and eluted in 50 µL. Saliva samples with too much mucus were mixed 1:1 with a sputum lysis buffer containing N-acetylcystein (10 g/L) and were shaken for 30 min. A semi-quantitative real-time reverse transcription polymerase chain reaction (rRT-PCR) was performed using the AgPath-ID One-step RT-PCR kit (No. 4387391, Life Technologies, Carlsbad, CA, USA) with primers and probes targeting two SARS-CoV-2 RdRp gene targets, developed at Institut Pasteur (Paris, France), and shared in the WHO protocol inventory [13]. A 25 µL reaction was set up, containing 5 µL of RNA. Criteria for a positive reaction were a cycle of threshold (Ct) value of less than 40 for both PCR targets and a credible amplification curve. Inconclusive results were resolved by repeating tests.
The project coordinator notified all participants about the test-results. The median number of days between the date of the last exposure (contact with the index case) and the date of the first saliva sample was four (range: three to six days). The median number of days between the two saliva samples was six (range: three to ten days).
Samples from all positive cases were whole genome sequenced using two multiplexed amplicon approaches; ARTIC-network nCoV-19 protocol v.3 [15,16] (available at https://arctic.network/ncov-2019, accessed on 1 December 2021), run on either the Illumina MiSeq platform (Illumina Inc, San Diego, CA, USA), the NanoPore GridIon (Oxford Nanopore Technologies, Oxford, UK); or the Swift Amplicon SARS-CoV-2 Panel (Swift Biosciences, Ann Arbor, MI, USA) on Illumina NovaSeq (Illumina Inc, San Diego, CA, USA) at the Norwegian Sequencing Centre, Oslo University Hospital, according to the manufacturer’s instructions with minor modifications. We used the PANGO lineages nomenclature (https://github.com/cov-lineages/pangolin, accessed on 28 September 2021) to define the SARS-CoV-2 variant [17]. Sequences were aligned in a codon-aware manner to the reference genome Wuhan-Hu-1 (GenBank accession no: MN908947.3) using the program Nextalign v.0.2.0 (available at https://github.com/nextstrain/nextclade, accessed on 1 December 2021), and a maximum-likelihood phylogenetic tree was created using IQTREE v.2.0.3 (available at https://iqtree.org, accessed on 1 December 2021) [18]. Pairwise single nucleotide polymorphism (SNP) analysis determined possible transmission in contact tracings with primary or secondary cases identified. We considered contacts with a SNP distance of 0–2 SNPs as verified transmissions [19].
For quality assessment purposes we linked the study data with the laboratory results from the national laboratory database in the Norwegian Surveillance System for Communicable Diseases (MSIS) through the participants’ unique national identity numbers. We obtained data from MSIS from the two weeks prior to the date of the first saliva sample and four weeks after the date of the second saliva sample, or the first sample when we did not receive a second sample.

2.4. Epidemiological Data

We obtained data on the local COVID-19 incidence rate over the last 14 days prior to date of sample collection for diagnosis of the index case in each contact-investigation. To assess possible underestimation of transmission due to non-participation we obtained aggregated data from the municipal health officer on the number of contacts with confirmed SARS-CoV-2 identified in the routinely performed contact investigation. In the municipalities, testing of all contacts was only routine in the second half of the academic year.
An overview of data and sources is presented in Appendix A Table A1.

2.5. Mitigation Measures in Schools

Semi-structured phone interviews with school staff about mitigation measures were conducted in parallel with the contact investigations. Two researchers independently categorized the responses into eight broad categories (Box 1) and scored the schools’ IPC measures on a scale from 0 to 8, with higher scores indicating higher consistency with national guidelines relative to the traffic light model. The scoring system was based on expert opinions. In case of discordant opinions, a third author was included to reach consensus. Each school’s IPC-score is available in Appendix A Table A2.
Box 1. Categories of infection prevention and control measures in schools.
Stay at home policy for all if symptomatic
Enforced classroom hygiene
Defined child cohorts, limited mixing of cohorts
Limit shared spaces for children indoors
Limit shared spaces for children outdoors
Reduce the number of staff involved in each cohort
Reduce physical contact between staff
Work-from-home policy for staff whenever possible

2.6. Analyses

We calculated the percentages of the primary, secondary and all SARS-CoV-2 positive contacts among all contacts with 95% confidence intervals, excluding index cases both in the numerator and the denominator. For secondary cases we also excluded primary cases and contacts who did not provide a second saliva sample (n18, 3%) from the denominator. Comparison between the groups was made using Fisher’s exact test (p-value ≤ 0.05). Descriptive measures other than percentages are presented as median (range).
All data was analyzed using STATA, (StataCorp. LLC, Release 16, College Station, TX, USA).

3. Results

The study includes 43 contact investigations in Oslo and Viken counties from August 2020 until May 2021, with 559 child and 100 adult contacts, as seen in Table 1. Eleven (26%) contact investigations were included in the period in which Alpha was dominant. Overall, 60% (559/935) of child contacts and 63% (100/158) of adult contacts consented to participate in the study. The median participation for child and adult contacts was lower in the Alpha period compared to the pre-Alpha period (Table 1).
Among index cases, 79% (34) consented to participate. At the time of enrolment, 44% (15) reported to have symptoms; six reported fever with at least one other symptom and nine reported other symptoms without fever. Two index cases did not respond to the question. Among those without symptoms at enrolment, two additional indexes reported fever during follow-up.
The local incidence rate in the municipality of the Oslo borough over the two weeks prior to the initiation of the contact investigation showed large variation over time and place and ranged from 17–763 cases per 100,000. The corresponding incidence rates for Oslo and Viken counties ranged from 29–471 cases per 100,000, (Appendix A Table A2). The IPC-measures in schools were on red level according to the traffic-light model during 40% (17) of the contact investigations, and on yellow level in the remaining cases.

3.1. Infection Rates

The primary and secondary infection rates remained <1% in both the pre-Alpha and the Alpha period, with overlapping confidence intervals, and at 1.4% overall (see Table 2). We found no statistically significant difference in the overall infection rates in the pre-Alpha and Alpha period (Fisher’s exact test, p = 0.665). Only one primary case and no secondary cases were identified in the lowest grades (1–4th). The percentage infected contacts was higher in secondary than in primary schools, but the difference was not statistically significant (p = 0.229), and the percentage remained low (see Table 2).
Only one adult contact (1/100, 1%) tested positive in the study with SARS-CoV-2 confirmed in the first saliva sample (primary case) in the pre- Alpha period (5th–7th grade).

3.2. Characteristics of the Virus

Among the 34 index cases who consented to participate, whole genome sequencing (WGS) identified 13 different SARS-CoV-2 Pango lineage variants [17] in 33 index cases (see Table 3). For one index case, WGS failed due to low viral RNA content in the sample (PCR cycle threshold Ct > 33). The B.1.1.7 (Alpha) was the most frequent variant.
Four of the nine index cases that did not consent to participate were enrolled during the Alpha-period. We assume that these contacts were exposed to the more transmissible Alpha variant, since this was the dominant variant in this period, growing from ~80% in the beginning of March to ~95% by the end of May 2021 [12].

3.3. Possible Transmission

Primary or secondary cases were identified in eight separate contact investigations (see Table 4). In four of the contact-investigations (ID 08; 14; 17; 24), matching SARS-CoV-2 Pango lineages were identified in index cases and the corresponding primary or secondary cases. The phylogenetic analysis showed ≤2 SNPs difference between cases in these contact investigations, consistent with direct transmission among cases (Figure 1). Transmission can be ruled out in one contact investigation due to different Pango lineages in the index and contact (ID 30). We were unable to study transmission in the remaining pairs, since WGS failed in two secondary cases due to low viral RNA content in the sample (ID 28; 41), and one index case (ID 33) did not consent to participate.
The phylogenetic analysis showed that SARS-CoV-2 viruses were more similar within than between schools, with some exceptions (see Figure 1). Analysis of the B.1.367 linage showed ≤2 SNPs difference among the index cases (ID-03; 04; 06) from three schools in neighboring communities in September and October 2020. This probably reflects indirect, rather than direct, transmission since this SARS-CoV-2 variant dominated in this geographic area during the specific time period. Similar interpretations can be assigned to the B.1.36.21, B.1.1.305 and K.3 lineages, where index cases were identified with similar viruses (≤2 SNP differences) close in time.

3.4. Study Data Compared with Surveillance Data

Linkage of the study data with national laboratory data revealed that 63% (434) of the participants had test results from testing outside of the study within two weeks prior to the date of the first saliva sample and four weeks after the date of the second saliva sample; 56% (333) in the pre-Alpha period versus 93% (101) in the Alpha-period. The large difference between the periods reflects the change in the recommendations and easier access to and availability of tests in the Alpha period. Concordance of test results from the two sources was high, at 98% (427/434). Among the seven individuals with discordant results, two were index cases with negative saliva tests; one had been drinking milk before the saliva collection, and the other had low viral RNA content in the original sample. Among the five contacts, four had a negative test reported from the study or MSIS 3–10 days prior to a positive result, which may reflect a natural course of the disease or a later exposure. One contact tested negative one month after a positive test result.
Data from the municipalities show that they identified five additional SARS-CoV-2 positive cases among contacts who had not consented to participate in the study; four children (primary school) and one adult (secondary school), in total 12 positive cases out of a total of 935 (1.3%, 95%CI 0.67–2.23) contacts; nine in the pre-Alpha period and three in the Alpha period. It was not possible to distinguish between primary and secondary cases among these. Comparison of infection rates in contacts not enrolled and those enrolled in the study was not significantly different, as determined by using Fisher’s exact test (p-value ≤ 0.05).

3.5. Mitigation Measures in School

Data on IPC-measures is available from 39 of the 43 schools. Overall, mitigation measures were well implemented and consistent with national guidelines (Appendix A Table A2). The median IPC score was 7 (range 6–8). The median score was higher in the Alpha than the preAlpha-period, Table 1. More details are available in Appendix A Table A3. Nine schools reported insufficient physical distancing of children indoors; three due to shared indoor spaces, four due to the mixing of child cohorts and two schools because they are based on an educational model in which children engage in more self-directed group work. Six schools reported insufficient physical distancing of staff, due to shared office space across staff cohorts and physical attendance in meetings. Promotion of a work-from-home policy when possible was the measure least likely to be implemented. This was only implemented in 18% (7/39) of the schools, and mainly in the second half of the academic year only (Appendix A Table A3).

4. Discussion

In this large-scale prospective study with rigorous follow-up and testing of all school contacts, we found only limited child-to-child and child-to-adult SARS-CoV-2 transmission in schools, and even lower rates when WGS was used to study possible transmission links. This holds also for the more transmissible Alpha variant. The study was carried out over nine months, covering the second and third COVID-19 waves in Norway. Since we excluded contact investigations with adult cases that were known at the time of enrolment, our data provide a valid estimate on the role of children in transmission of SARS-CoV-2 in schools.
A high number of primary cases could have indicated multiple introductions of SARS-CoV-2 into the school or ongoing asymptomatic infection prior to the diagnosis of the index case. However, few primary cases were detected and all with sequencing information available had matching SARS-CoV-2 Pango lineages with the corresponding index case. Little data are available to compare the primary and secondary infection rates in this study, while the overall infection rate of 1.4% among child contacts is similar to the 0%– 3% reported by others [20,21,22,23,24,25]. A recent meta-analysis, which was restricted to studies in which all contacts were tested (available as a Lancet preprint), reported a pooled secondary attack rate from child index cases in eight schools at 0.5% (95% CI: 0.1–0.16) [23]. Data, including a subset of data published as rapid communication from the current study [7], were mostly from the pre-Alpha period. Their pooled estimate is lower than the overall infection rate reported in our study. However, the number of contacts per case differed widely between studies (range 10–297), which may have impact on secondary attack rates.
Only one out of 100 adult contacts tested positive for SARS-CoV-2. Low child-to-adult transmission in school-settings is also reported by others [4,20,24]. These findings are underpinned by population-based studies showing that educational staff are more likely to transmit the disease to students than vice-versa [26], and that the incidence among teachers is comparable to the population of the same age [27].
The Alpha variant has been shown to be more transmissible compared to earlier variants in all age groups [28]. Yet, its role in transmission in school settings is not clear. A study from England suggested that the rise in school absences observed in secondary schools in England in December 2020 in the areas where the Alpha variant first emerged, followed a preceding rise in COVID-19 incidences in the affected communities, therefore reflects higher community incidences rather than in-school transmission [29]. Several studies have pointed to the interdependency between the community infection level and infections in schools [4,30]. We found negligible differences in primary and secondary infection rates in the pre-Alpha and Alpha periods. However, the number of included contact-investigations were lower in the Alpha period; half of them were in 1–4th grade, where secondary attack rates are reported to be lower [4]. In addition, many schools were on the red IPC level with smaller cohorts and more comprehensive mitigation measures at the time that the Alpha-variant established itself in Norway. On September 3rd, 2021, the European Centre for Disease Control downgraded the Alpha variant from a variant of concern to a de-escalated variant, due to its limited impact on vaccine-induced immunity and the drastically reduced circulation following the emergence of the Delta variant (B.1.617.2) [31]. The Delta variant established itself in Norway during summer, when schools were closed, and is therefore not reflected in our study results.
Overall, WGS of the virus revealed high consistency in the variants between index cases and the corresponding primary and secondary cases, indicating that the cases were related, either through direct transmission or that they were infected from a common source. However, the direction of transmission is not necessarily clear. Being identified as the index case may simply reflect that they were the first to be tested. We also found indexes in separate contact investigations to have matching Pango lineage variants with ≤2 SNPs differences. Although direct transmission outside the school setting cannot be ruled out, this likely reflects indirect community transmission.
Home sampling of saliva is susceptible to poor sampling procedures. Parents were given face-to-face detailed instructions on how to support their children in providing saliva samples at home. Reassuringly, we found very high consistency between the saliva test results in the study and results from routine nasopharyngeal swabs in the community.
Mitigation measures were well implemented overall, although less comprehensively for staff than for children. Measures to reduce the number of contacts and to maintain distance among the remaining contacts will inevitably prevent transmission. However, evidence on the effectiveness of mitigation measures are scarce and somewhat heterogeneous [32]. Measures are commonly implemented as packages, making it difficult to disentangle the effect of the individual interventions. A recent modelling study reported a dose-dependent relationship between the number of mitigation measures implemented in schools and the COVID-19 incidence in households; when ≥7 mitigation measures were implemented there was no significant association between the two [33]. When treated as independent effects, daily symptom screening, teacher mask mandates and cancelling of extra-curricular activities were associated with greater reductions than the average [33]. The use of masks has not been recommended in the classroom setting in Norway for staff or students.
The study has contributed to the policy in Norway where primary schools have remained open with strict mitigation measures throughout the study period, and secondary schools have only had limited periods of distant learning in periods of high community transmission.
The strengths of this study include the large number of contact investigations with comprehensive data and testing of all enrolled contacts. The study covered low- and high-incidence periods, including the period before and after the Alpha variant emerged. Reassuringly we found similar infection rates in the study, as reported by the municipalities, implying non-selective participation. Further, the saliva test results showed high concordance with surveillance data, implying that our results were valid. WGS improved the validity of the results as it allowed us to verify whether the index and related contacts were infected by an identical (≤2 SNPs) strain, as well as excluding transmission in one contact investigation. This could have been misinterpreted by solely using PCR-based typing.
We did not include consecutive contact-investigations in schools following primary- or secondary cases, which may lead to underestimation of our study findings. The results are not necessarily directly applicable to new variants of SARS-CoV-2, such as the highly transmissible Delta variant (B.1.617.2 and AY.x) and new variants which may emerge. These studies are also important to conduct for new variants, to ensure that the measures to control transmission are well balanced against educational needs for children.

5. Conclusions

We found limited child-to-child and child-to-adult transmission of SARS-CoV-2 in schools, which also holds for the Alpha variant. Since we excluded contact investigations with adult cases known at the time of enrollment, our data provide a valid estimate on the role of children in transmission of SARS-CoV-2 in schools. Looking only at outbreaks in schools in general, without considering contribution of adults in transmission, may overestimate the role of children in transmission.

Author Contributions

B.A.W., L.T.B., H.M., R.R., K.B. and K.N. were responsible for conceptualization of the study. B.A.W., H.M., L.T.B., O.B.B. contributed to data curation. B.A.W., H.M., O.B.B., L.T.B. contributed to formal analysis. B.A.W., T.S.O., L.T.B., O.H., R.R., H.M.L. contributed to the investigations. B.A.W., L.T.B., H.M., K.B., O.H., R.R., O.B.B. contributed to methodology. B.A.W., T.S.O., L.T.B. were responsible for project administration. K.B., K.N., M.G.-I. contributed with supervision within their field of expertise. B.A.W., H.M., T.S.O., L.T.B., R.R. validated the data. O.B.B., L.T.B. analyzed and visualized the sequencing data. B.A.W. wrote the original draft. All authors critically reviewed the final version of the manuscript, have confirmed access to the data, and accepted responsibility to submit for publication. B.A.W., H.M., L.T.B. and T.S.O. verified the underlying data. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding and was funded in full by the Norwegian Institute of Public Health.

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki, and was approved by the Regional Committees for Medical and Health Research Ethics in Norway (reference 151649 on 16 June 2020). The study complies with the EU general data protection regulation (GDPR) requirements.

Informed Consent Statement

The informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data presented in this study are available on request from the corresponding author. De-identified data are not publicly available due to regulations in the Norwegian Health Research Act and the Norwegian Data Protection Act for use (and storage) of Personal Data related to health. To receive access to the data the applicant will need to provide an ethical approval from their IRB or equivalent body, and from Regional Committees for Medical and Health Research Ethics in Norway.

Acknowledgments

We thank municipality doctors and school administrators in Oslo and Viken for close and beneficial collaboration, as well as all participants for their contributions to the study. We thank the medical microbiologists (Dagny Haug Dorenberg and Kirsten Bjerkreim Strand) and laboratory technicians at the National Reference Laboratory of influenza and coronaviruses with outbreak potential (including SARS-CoV-2) at the Department of Virology at NIPH for managing the samples, performing the laboratory analyses and reporting the results. Further, we want to thank Kathrine Stene-Johansen and the NGS working group at NIPH for implementing and organizing the SARS-CoV-2 WGS analysis. Finally, we acknowledge the other members of the Corona Child Study group at NIPH: Cathinka Halle Julin, Anja Bråthen Kristoffersen, Camilla Svendsen, Sylvi K Ladehaug and Thor Indseth for practical input and fruitful discussions. We thank the Norwegian Surveillance System for Communicable Diseases for background data on COVID-19 prevalence, and finally the NIPH for funding the study.

Conflicts of Interest

The authors declare no conflict of interest. Except for employees directly involved in the study, NIPH were not involved in the study design, conduct or the interpretation of data.

Appendix A

Table A1. Overview of study data and data sources.
Table A1. Overview of study data and data sources.
SourceLevel
Home-sampled saliva test, study start *All participants
Home-sampled saliva test, study end *All participants
Questionnaire 1—Demography and previous exposure All participants
Questionnaire 2—Symptom diaryAll participants
Questionnaire 3—Outcome and exposureContacts negative for SARS-CoV-2 in the first saliva sample
WGS data-cases *Cases and contacts with confirmed SARS-CoV-2
Linkage with MSIS laboratory database All participants
Infection prevention and control measuresParticipating Schools
Outcome of contact investigation, municipalitiesPopulation, aggregated
Epidemiological dataPopulation, aggregated
WGS: Whole Genome Sequencing, MSIS: Norwegian Surveillance System for Infectious Diseases; * all laboratory analyses were done at the influenza reference laboratory at the Norwegian Institute of Public Health.
Table A2. Characteristics of the contact-investigations.
Table A2. Characteristics of the contact-investigations.
ID IQuarter/YearGradeCountyIR (/100,000) $IPC II-LevelChild ContactsAdult Contacts
CountyLocalNational #Scores (Local) §Total nIncluded n (%)Total nIncluded n
1st to 4th grade
1 *Q3-20201–4Viken3417 73015 (50)123
2 *Q3-20201–4Viken2926 74533 (73)94
3 *Q3-20201–4Viken2926 41816 (89)32
4 *Q4-20201–4Viken3139 52219 (86)97
5 *Q4-20201–4Viken3151 72217 (77)55
6 *Q4-20201–4Viken3151 7194 (21)52
7 *Q4-20201–4Oslo9955 62218 (82)77
8 *Q4-20201–4Oslo181150 52418 (71)43
9Q4-20201–4Oslo336251 62114 (67)11
10Q2-20211–4Oslo441763 -134 (31)11
11Q2-20211–4Oslo471433 73720 (54)34
12Q2-20211–4Oslo284267 81813 (72)10
13Q2-20211–4Viken141204 794 (44)11
14Q2-20211–4Viken118337 7106 (60)41
15Q2-20211–4Viken109152 81913(14)33
5th to 7th grade
16 *Q3-20205–7 Oslo5365 72017 (85)32
17 *Q4-20205–7 Oslo9955 62520 (80)32
18 *Q4-20205–7 Oslo9596 62417 (71)62
19 *Q4-20205–7 Oslo111111 6258 (28)33
20 *Q4-20205–7 Oslo181276 62115 (71)43
21Q4-20205–7 Oslo254354 51610 (63)10
22Q4-20205–7 Viken209522 7159 (60)11
23Q4-20205–7 Viken194179 -1714 (82)21
24Q4-20205–7 Viken182158 71810 (56)00
25Q1-20215–7 Viken144201 74131 (76)21
26Q1-20215–7 Viken144171 72015 (70)52
27Q2-20215–7 Oslo363211 8104 (40)10
28Q2-20215–7 Oslo284419 -146 (43)31
29Q2-20215–7Oslo212179 72412 (50)42
8th to10th grade
30Q4-20208–10Oslo181150 52116 (76)32
31Q4-20208–10Oslo254354 7223 (14)10
31Q4-20208–10Oslo254429 62312 (52)41
33Q4-20208–10Oslo336438 52514 (56)86
34Q4-20208–10Oslo336415 52819 (68)41
35Q4-20208–10Oslo336415 6194 (16)53
36Q4-20208–10Oslo294239 8135 (38)41
37Q4-20208–10Viken194179 -1810 (56)31
38Q4-20208–10Oslo223365 82317 (74)22
39Q1-20218–10Viken202268 7146 (50)12
40Q1-20218–10Viken190159 8106 (60)51
41Q1-20218–10Viken190269 6209 (45)11
42Q1-20218–10Viken195335 76232 (52)63
43Q1-20218–10Oslo471637 7184 (22)33
I ID; identifier for each contact-investigation; * A subset of the data from the contact-investigations ID number 1–12 and 14 have been published earlier [7]; $ IR (/100,000) the last 14 days prior to date of clinical sample collection of the index case in Oslo and Viken counties and in communities or boroughs (local); II IPC; Infection Prevention and Control measures; # National Infection Prevention and Control guidelines for schools used a traffic light model based on infection pressure to indicate level of IPC measures. Red light implies strongest containment strategies [9]; § IPC measures in affected schools were classified and scored (0–8) according to a standard format. Higher scores indicates higher consistency with national guidelines. See Appendix A Table A3 for details.
Table A3. Infection Prevention and Control (IPC) measures.
Table A3. Infection Prevention and Control (IPC) measures.
IDQuarterGradeNational Guideline/Traffic Light ModelSum of ScoresNational Guidelines
ABCDEFGH
1Q3-20201–4 7
25–7 7
31–4 7
41–4 4
5Q4-20201–4 5
61–4 7
71–4 7
81–4 6
95–7 6
105–7 6
115–7 6
121–4 5
138–10 5
145–7 6
155–7 5
168–10 7
178–10 6
188–10 5
191–4 6
208–10 5
218–10 6
225–7 7
238–10 8
245–7 -
258–10 -
268–10 8
275–7 7
28Q1-20218–10 7
298–10 8
308–10 6
315–7 7
325–7 7
338–10 7
348–10 7
35Q2-20211–4 -
361–4 7
375–7 8
381–4 8
395–7 -
401–4 7
415–7 7
421–4 7
431–4 8
Yellow level according to traffic light modelAStay at home policy for all if symptomatic
BEnforced classroom hygiene
Red level according to traffic light modelCDefined child cohorts, reduced mixing of cohorts
DAvoid shared spaces for children indoors
IPC consistent with national guideline, score = 1EAvoid shared spaces for children outdoors
FReduce the number of staff contacts per child
IPC not consistent with national guideline, score = 0GReduce physical contact between staff
HPromotion of home-office whenever possible
ID; identifier of each contact-investigation, IPC; Infection Prevention and Control measures.

References

  1. Dong, Y.; Mo, X.; Hu, Y.; Qi, X.; Jiang, F.; Jiang, Z.; Tong, S. Epidemiology of COVID-19 among Children in China. Pediatrics 2020, 145. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Lu, X.; Zhang, L.; Du, H.; Zhang, J.; Li, Y.Y.; Qu, J.; Wong, G.W. SARS-CoV-2 Infection in Children. N. Engl. J. Med. 2020, 382, 1663–1665. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Viner, R.M.; Mytton, O.T.; Bonell, C.; Melendez-Torres, G.J.; Ward, J.; Hudson, L.; Eggo, R.M. Susceptibility to SARS-CoV-2 Infection among Children and Adolescents Compared with Adults: A Systematic Review and Meta-analysis. JAMA Pediatr. 2021, 175, 143–156. [Google Scholar] [CrossRef] [PubMed]
  4. Ismail, S.A.; Saliba, V.; Bernal, J.L.; Ramsay, M.E.; Ladhani, S.N. SARS-CoV-2 infection and transmission in educational settings: A prospective, cross-sectional analysis of infection clusters and outbreaks in England. Lancet Infect. Dis. 2021, 21, 344–353. [Google Scholar] [CrossRef]
  5. European Centre for Disease Prevention and Control. COVID-19 in Children and the Role of School Settings in Transmission-Second Update; ECDC: Stockholm, Sweden, 2021.
  6. Brurberg, K.G. The role of children in the transmission of SARS-CoV-2(COVID-19), 1st update. Nor. Inst. Public Health 2020, 3, D5140. [Google Scholar]
  7. Brandal, L.T.; Ofitserova, T.S.; Meijerink, H.; Rykkvin, R.; Lund, H.M.; Hungnes, O.; Winje, B.A. Minimal transmission of SARS-CoV-2 from paediatric COVID-19 cases in primary schools, Norway, August to November. Eurosurveillance 2021, 26, 2002011. [Google Scholar] [CrossRef]
  8. Flasche, S.; Edmunds, W.J. The role of schools and school-aged children in SARS-CoV-2 transmission. Lancet Infect. Dis. 2021, 21, 298–299. [Google Scholar] [CrossRef]
  9. Laxminarayan, R.; Wahl, B.; Dudala, S.R.; Gopal, K.; Neelima, S.; Reddy, K.J.; Lewnard, J.A. Epidemiology and transmission dynamics of COVID-19 in two Indian states. Science 2020, 370, 691–697. [Google Scholar] [CrossRef]
  10. Johansen, T.B.; Astrup, E.; Jore, S.; Nilssen, H.; Dahlberg, B.B.; Klingenberg, C.; Greve-Isdahl, M. Infection prevention guidelines and considerations for paediatric risk groups when reopening primary schools during COVID-19 pandemic, Norway, April 2020. Eurosurveillance 2020, 25, 2000921. [Google Scholar] [CrossRef]
  11. Al Suwaidi, H.; Senok, A.; Varghese, R.; Deesi, Z.; Khansaheb, H.; Pokasirakath, S.; Alsheikh-Ali, A. Saliva for molecular detection of SARS-CoV-2 in school-age children. Clin. Microbiol. Infect. 2021, 27, 1330–1335. [Google Scholar] [CrossRef]
  12. Norwegian Institute of Public Health. Genomic Epidemiology of Novel Coronavirus-Norway All Focused Subsampling; Norwegian Institute of Public Health: Oslo, Norway, 2021; Available online: https://nextstrain.org/groups/niph/ncov/norway-all-2021-06-07?c=pango_lineage (accessed on 29 September 2021).
  13. World Health Organization. Protocol: Real-Time RT-PCR Assays for the Detection of SARS-CoV-2; Institut Pasteur: Paris, France; Available online: https://www.who.int/docs/default-source/coronaviruse/real-time-rt-pcr-assays-for-the-detection-of-sars-cov-2-institut-pasteur-paris.pdf (accessed on 8 June 2021).
  14. Lauvrak, V.; Juvet, L.K. Saliva Sample for Testing SARS-CoV-2 Infection, 1st Update Ondiagnostic Accuracy; Norwegian Institute of Public Health: Oslo, Norway, 2020; Available online: https://fhi.brage.unit.no/fhi-xmlui/handle/11250/2722753 (accessed on 13 February 2021).
  15. Quick, J. nCoV-2019 Sequencing Protocol v3 (LoCost) V.3. Available online: https://www.protocols.io/view/ncov-2019-sequencing-protocol-v3-locost-bh42j (accessed on 8 June 2021).
  16. Tyson, J.R.; James, P.; Stoddart, D.; Sparks, N.; Wickenhagen, A.; Hall, G.; Quick, J. Improvements to the ARTIC multiplex PCR method for SARS-CoV-2 genome sequencing using nanopore. bioRxiv 2020. [Google Scholar] [CrossRef]
  17. Rambaut, A.; Holmes, E.C.; O’Toole, Á.; Hill, V.; McCrone, J.T.; Ruis, C.; Pybus, O.G. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology. Nat. Microbiol. 2020, 5, 1403–1407. [Google Scholar] [CrossRef] [PubMed]
  18. Minh, B.Q.; Schmidt, H.A.; Chernomor, O.; Schrempf, D.; Woodhams, M.D.; Von Haeseler, A.; Lanfear, R. IQ-TREE 2: New Models and Efficient Methods for Phylogenetic Inference in the Genomic Era. Mol. Biol. Evol. 2020, 37, 1530–1534. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  19. San, J.E.; Ngcapu, S.; Kanzi, A.M.; Tegally, H.; Fonseca, V.; Giandhari, J.; de Oliveira, T. Transmission dynamics of SARS-CoV-2 within-host diversity in two major hospital outbreaks in South Africa. Virus Evol. 2021, 7, veab041. [Google Scholar] [CrossRef]
  20. Larosa, E.; Djuric, O.; Cassinadri, M.; Cilloni, S.; Bisaccia, E.; Vicentini, M. Secondary transmission of COVID-19 in preschool and school settings in northern Italy after their reopening in September 2020: A population-based study. Eurosurveillance 2020, 25, 2001911. [Google Scholar] [CrossRef] [PubMed]
  21. Heavey, L.; Casey, G.; Kelly, C.; Kelly, D.; McDarby, G. No evidence of secondary transmission of COVID-19 from children attending school in Ireland, 2020. Eurosurveillance 2020, 25, 2000903. [Google Scholar] [CrossRef]
  22. Yung, C.F.; Kam, K.Q.; Nadua, K.D.; Chong, C.Y.; Tan, N.W.H.; Li, J. Novel Coronavirus 2019 Transmission Risk in Educational Settings. Clin. Infect. Dis. 2021, 72, 1055–1058. [Google Scholar] [CrossRef]
  23. Viner, R.M.; Waddington, C.; Mytton, O.; Booy, R.; Ladhan, S.; Panovska-Griffiths, J.; Bonnel, J.; Melendez-Torres, G.J. Children and Young People in Households and Schools: A Meta-Analysis of Population-Based and Contact-Tracing Studies. Lancet 2021. [Google Scholar]
  24. Macartney, K.; Quinn, H.E.; Pillsbury, A.J.; Koirala, A.; Deng, L.; Winkler, N. Transmission of SARS-CoV-2 in Australian educational settings: A prospective cohort study. Lancet Child. Adolesc. Health 2020, 4, 807–816. [Google Scholar] [CrossRef]
  25. Macartney, K. COVID-19 in Schools and Early Childhood Education and Care Services-the Term 4 Experience in NSW; National Centre for Immunisation Research and Surveillance: Sydney, Australia, 2021; Available online: https://www.ncirs.org.au/sites/default/files/2021-03/NCIRS%20NSW%20Schools%20COVID_Summary_Term%204%202020%20Report.pdf (accessed on 13 September 2021).
  26. Schoeps, A.H.D.; Tamm, C. COVID-19 transmission in educational institutions August to December 2020 Germany: A study of index cases and close contact cohorts. medRxiv 2021. [Google Scholar] [CrossRef]
  27. Gandini, S.; Rainisio, M.; Iannuzzo, M.L. A cross-sectional and prospective cohort study of the role of schools in the SARS-CoV-2 second wave in Italy. Lancet Reg. Health Eur. 2021, 5, 100092. [Google Scholar] [CrossRef] [PubMed]
  28. Public Health England. SARS-CoV-2 Variants of Concern and Variants under Investigation in England-Technical Briefing 14. 2021. Available online: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/991343/Variants_of_Concern_VOC_Technical_Briefing_14.pdf (accessed on 16 September 2021).
  29. Southall, E.; Holmes, A.; Hill, E.M.; Atkins, B.D.; Leng, T.; Thompson, R.N. An analysis of school absences in England during the COVID-19 pandemic. BMC Med. 2021, 19, 137. [Google Scholar] [CrossRef] [PubMed]
  30. Willeit, P.; Krause, R.; Lamprecht, B. Prevalence of RT-qPCR-detected SARS-CoV-2 infection at schools: First results from the Austrian School-SARS-CoV-2 prospective cohort study. Lancet Reg. Health Eur. 2021, 5, 100086. [Google Scholar] [CrossRef]
  31. European Centre for Disease Prevention and Control. SARS-CoV-2 Variants of Concern as of 23 September 2021; ECDC: Stockholm, Sweden, 2021. Available online: https://www.ecdc.europa.eu/en/covid-19/variants-concern (accessed on 29 September 2021).
  32. Krishnaratne, S.; Pfadenhauer, L.M.; Coenen, M.; Geffert, K.; Jung-Sievers, C.; Klinger, C. Measures implemented in the school setting to contain the COVID-19 pandemic: A scoping review. Cochrane Database Syst. Rev. 2020, 12, CD013812. [Google Scholar] [CrossRef] [PubMed]
  33. Lessler, J.; Grabowski, M.K.; Grantz, K.H.; Badillo-Goicoechea, E.; Metcalf, C.J.E. Household COVID-19 risk and in-person schooling. Science 2021, 4, 1092–1097. [Google Scholar] [CrossRef]
Figure 1. Maximum likelihood phylogenetic tree of SARS-CoV-2 strains from cases included in contact investigations (n, 33), Oslo and Viken, August 2020–May 2021; SNP; single nucleotide polymorphism; the whole genome sequencing failed due to low viral load in two of the secondary cases, and one the index case did not consent to participate.
Figure 1. Maximum likelihood phylogenetic tree of SARS-CoV-2 strains from cases included in contact investigations (n, 33), Oslo and Viken, August 2020–May 2021; SNP; single nucleotide polymorphism; the whole genome sequencing failed due to low viral load in two of the secondary cases, and one the index case did not consent to participate.
Microorganisms 09 02587 g001
Table 1. Characteristics of the study population in 43 contact investigations in Oslo and Viken, August 2020 to May 2021.
Table 1. Characteristics of the study population in 43 contact investigations in Oslo and Viken, August 2020 to May 2021.
Whole Study PeriodPre-AlphaAlpha
Number of contact investigations, all (n, %)433211
1–4th grade15 (35)9 (28)6 (55)
5–7th grade14 (33)11 (34)3 (27)
8–10th grade14 (33)12 (38)2 (18)
Number of child contacts, all (n, %)599441118
1–4th grade214 (36)154 (35)60 (51)
5–7th grade188 (31)166 (38)22 (19)
8–10th grade157 (26)121 (27)36 (31)
Number of adult contacts, all (n, %)1008119
1–4th grade53 (53)43 (53)10 (53)
5–7th grade20 (20)17 (21)3 (16)
8–10th grade27 (27)21 (26)6 (32)
Number of child contacts per index case (median, range) #13 (3–33)15 (4–33)6 (4–32)
Participation child contacts (median, range) #60 (14–89)68 (14–89)44 (14–72)
Number of adult contacts per index case (median, range) #2 (0–12)2 (0–12)1 (0–3)
Participation adult contacts (median, range) #67 (0–100)67 (0–100)50 (0–100)
IPC-score (median, range)7 (6–8)6 (5–8)7 (6–8)
IPC-score, Infection Prevention and Control (mitigation) measures, scored on a scale from 0–8 with higher scores indicating higher consistency with national guidelines; pre-Alpha and Alpha reflects the period before and after the Alpha variant (B.1.1.7) was established (August–February versus March–May); # Participation was calculated as the percentage of included contacts of all identified contacts per contact-investigation, presented as median (%) and range (%–%).
Table 2. Primary, secondary and all infected child contacts detected in school contact investigations (n, 43) within 7–10 days following the last exposure, Oslo and Viken, August 2020–May 2021.
Table 2. Primary, secondary and all infected child contacts detected in school contact investigations (n, 43) within 7–10 days following the last exposure, Oslo and Viken, August 2020–May 2021.
Number of Contacts, n (n) #Primary I Cases,
n (%, 95% CI)
Secondary II Cases,
n (%, 95% CI)
All Infected Cases III
n (%, 95% CI)
All child contacts559 (537)4 (0.7, 0.20–1.82)4 (0.7, 0.20–1.90)8 (1.4, 0.62–2.80)
pre-Alpha *441 (426)3 (0.7, 0.14–1.97)3 (0.7, 0.15–2.04)6 (1.4, 0.50–2.94)
Alpha *118 (111)1 (0.9, 0.02–4.63)1 (0.9, 0.02–4.92)2 (1.7, 0.21–5.99)
Child contacts by school grade
Child contacts, grade 1–4 (all)214 (206)1 (0.5, 0.01–2.58)01 (0.5, 0.01–2.58)
pre-Alpha154 (148)1 (0.7, 0.02–3.56)01 (0.7, 0.02–3.56)
Alpha60 (58)000
Child contacts, grade 5–7 (all)188 (183)1 (0.5, 0.01–2.93)2 (1.1, 0.13–3.89)3 (1.6, 0.33–4.59)
pre-Alpha166 (163)1 (0.6, 0.02–3.31)1 (0.6, 0.02–3.37)2 (1.2, 0.15–4.28)
Alpha22 (20)01 (5.0, 0.13–22.87)1 (4.5, 0.12–22.84)
Child contacts, grade 8–10 (all)157 (148)2 (1.3, 0.15–4.53)2 (1.4, 0.16–4.58)4 (2.6, 0.70–6.39)
pre-Alpha121 (115)1 (0.8, 0.02–4.52)2 (1.8, 0.20–6.14)3 (2.5 0.51–7.07)
Alpha36 (33)1 (2.8, 0.07–14.5)01 (2.8, 0.07–14.53)
* pre-Alpha and Alpha reflects the period before and after the Alpha variant (B.1.1.7) was established (August–February versus March–May); # n (n) number of contacts, the parentheses represents the number of contacts with a second saliva sample; 18 (3%) child contacts did not provide a second saliva sample and primary cases were excluded; I a contact of the index case who tested positive for SARS-CoV-2 in the first saliva sample; II a contact of the index case who tested positive for SARS-CoV-2 in the second saliva sample, following a first negative test; III a contact who tested positive for SARS-CoV-2 in either of the two saliva tests, thus including both the primary and secondary cases.
Table 3. SARS-CoV-2 Pango lineage variants among child index cases (n, 33), Oslo and Viken, August 2020–May 2021.
Table 3. SARS-CoV-2 Pango lineage variants among child index cases (n, 33), Oslo and Viken, August 2020–May 2021.
SARS-CoV-2 Variant INumber of Contact
Investigations
Time of Contact-InvestigationPeriod #
B.1.1.77April 2021–May 2021Alpha
B.1.36.216November 2020–January 2021pre-Alpha
K.35October 2020pre-Alpha
B.1.3673September 2020–October 2020pre-Alpha
B.1.1.3053December 2020–January 2021pre-Alpha
B.1.12November 2020–January 2021pre-Alpha
Other *7September 2020–January 2021pre-Alpha
For one index case, the whole genome sequencing failed due to low viral RNA content in the sample; I Pango lineage nomenclature https://cov-lineages.org/index.html, accessed on 28 September 2021; # Period; pre-Alpha and Alpha reflects the period before and after the Alpha variant (B.1.1.7) was established (August–February versus March–May); * The following SARS-CoV-2 lineages occurred in only one index case each: B.1, B.1.1.39, B.1.1.277, B.1.177.44, B.1.177.82, B.1.177, and B.1.36.1.
Table 4. SARS-CoV-2 variants in contact investigations in which primary and secondary cases were detected (n, 8), Oslo and Viken, August 2020–May 2021.
Table 4. SARS-CoV-2 variants in contact investigations in which primary and secondary cases were detected (n, 8), Oslo and Viken, August 2020–May 2021.
IDPeriodSchool-GradeSARS-CoV-2 VariantSNP
Difference
Index
Case I
Primary Case IISecondary Case III
08pre-Alpha1–4K.3K.3 2 SNPs
14pre-Alpha5–7B.1.1B.1.1B.1.10 SNP
17pre-Alpha8–10B.1.36.21B.1.36.21 1 SNP
24pre-Alpha5–7B.1.1.305B.1.1.305 1 SNP
28pre-Alpha8–10B.1.1.305 WGS failedna
30pre-Alpha8–10B.1.36.21 B.1.1.333na
33Alpha8–10 B.1.1.7 na
41Alpha5–7B.1.1.7 WGS failed na
ID; identifier for each contact-investigation (reference, Appendix A Table A2); Period; pre-Alpha and Alpha reflects the periods before and after the Alpha variant (B.1.1.7) was established (August–February versus March–May); SNP; Single nucleotide polymorphism; I The index case was the child first identified with confirmed SARS-CoV-2 leading to the contact-investigation; II A contact of the index case who tested positive for SARS-CoV-2 in the first saliva sample; III A contact of the index case who tested positive for SARS-CoV-2 in the second saliva sample, following a first negative test.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Winje, B.A.; Ofitserova, T.S.; Brynildsrud, O.B.; Greve-Isdahl, M.; Bragstad, K.; Rykkvin, R.; Hungnes, O.; Lund, H.M.; Nygård, K.; Meijerink, H.; et al. Comprehensive Contact Tracing, Testing and Sequencing Show Limited Transmission of SARS-CoV-2 between Children in Schools in Norway, August 2020 to May 2021. Microorganisms 2021, 9, 2587. https://doi.org/10.3390/microorganisms9122587

AMA Style

Winje BA, Ofitserova TS, Brynildsrud OB, Greve-Isdahl M, Bragstad K, Rykkvin R, Hungnes O, Lund HM, Nygård K, Meijerink H, et al. Comprehensive Contact Tracing, Testing and Sequencing Show Limited Transmission of SARS-CoV-2 between Children in Schools in Norway, August 2020 to May 2021. Microorganisms. 2021; 9(12):2587. https://doi.org/10.3390/microorganisms9122587

Chicago/Turabian Style

Winje, Brita Askeland, Trine Skogset Ofitserova, Ola Brønstad Brynildsrud, Margrethe Greve-Isdahl, Karoline Bragstad, Rikard Rykkvin, Olav Hungnes, Hilde Marie Lund, Karin Nygård, Hinta Meijerink, and et al. 2021. "Comprehensive Contact Tracing, Testing and Sequencing Show Limited Transmission of SARS-CoV-2 between Children in Schools in Norway, August 2020 to May 2021" Microorganisms 9, no. 12: 2587. https://doi.org/10.3390/microorganisms9122587

APA Style

Winje, B. A., Ofitserova, T. S., Brynildsrud, O. B., Greve-Isdahl, M., Bragstad, K., Rykkvin, R., Hungnes, O., Lund, H. M., Nygård, K., Meijerink, H., & Brandal, L. T. (2021). Comprehensive Contact Tracing, Testing and Sequencing Show Limited Transmission of SARS-CoV-2 between Children in Schools in Norway, August 2020 to May 2021. Microorganisms, 9(12), 2587. https://doi.org/10.3390/microorganisms9122587

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop